Skip to main content

Table 1 Characteristics at baseline of completers of IMR versus non- completers

From: Illness Management & Recovery (IMR) in the Netherlands; a naturalistic pilot study to explore the feasibility of a randomized controlled trial

 

Total N = 81

Completers

N = 40

Dropouts from IMR N = 41

χ2 (df = 1)

p

OR

95 % CI

gender

male

48

59 %

 

19

29

4.53

.033*

2.67

[1.07, 6.67]

female

33

41 %

 

21

12

living situation

          

living alone

 

32

40 %

 

19

13

2.18

.139

0.48

[0.18, 1.28]

living with others

 

34

42 %

 

14

20

missing

 

15

18 %

       

education level

          

low

 

31

39 %

 

14

17

0.81

.369

1.59

[0.58, 4.36]

middle + high

 

30

37 %

 

17

13

missing

 

10

24 %

       

native country

          

born in Holland

 

42

52 %

 

22

20

0.47

.492

0.70

[0.25, 1.95]

immigrant

 

23

28 %

 

10

13

missing

 

16

20 %

       

diagnosis

          

psychotic disorders

 

59

73 %

 

31

28

0.58

.446

0.68

[0.25, 1.85]

All other diagnoses

 

21

26 %

 

9

12

missing

 

1

1 %

       

start of problems

          

<10 years ago

 

20

25 %

 

8

12

0.55

.457

1.50

[0.51, 4.38]

>10 years ago

 

44

54 %

 

22

22

missing

 

17

21 %

       

length of treatment

          

<5 years

 

17

21 %

 

6

11

1.42

.234

2.01

[0.63, 6.39]

>5 years

 

44

54 %

 

23

21

missing

 

20

25 %

       

number of admissions

          

None

 

12

15 %

 

6

6

0.04

.837

0.88

[0.25, 3.13]

≥1

 

45

56 %

 

21

24

missing

 

24

29 %

       

length hospitalization

          

<1 year

 

37

46 %

 

18

19

0.01

.928

1.06

[0.33, 3.41]

>1 year

 

16

20 %

 

8

8

missing

 

28

35 %

       

source of income

          

employment, unemployment or invalidity benefit

 

46

57 %

 

27

19

4.26

.039*

0.29

[0.09, 0.97]

social security benefit

 

17

21 %

 

5

12

missing

 

18

22 %

       
    

M (SD)

N

M (SD)

N

M (SD)

t (df)

 

Cohen’s d

 

Age

 

81

100 %

42.35 (10.12)

40

44.03 (8.70)

41

40.71 (11.20)

1.49 (75)

.140

0.33

[0.11, 0.77]

IMR-scale client version at baseline

 

66

82 %

3.36 (0.42)

36

3.46 (0.39)

30

3.24 (0.42)

2.21 (64)

.031*

0.55

[1.04, 0.05]

IMR-scale clinician version at baseline

 

70

86 %

3.09 (0.50)

37

3.22 (0.44)

33

2.94 (0.53)

2,41 (68)

.019*

0.58

[1.06, 0.10]

Recovery Markers Questionnaire [RMQ]

 

62

77 %

12.4 (5.76)

33

12.5 (5.55)

29

12.3 (6.1)

0.14 (60)

.890

0.04

[0.54, 0.46]

    

Mdn/IQR

 

Mdn/IQR

 

Mdn/IQR

U

p

r

 

GAF

 

79

98 %

50/10

39

55/10

40

50/10

591

.058

-.21

[-0.42, 0.01]

  1. *significant p < .05